Talus Bio (Seed+)
Funding Details
Awarder
RSS - theaiinsider.tech
Date Award
August 20, 2024
Vertical
Drug Discovery
Funding URL
View Funding Page
Premoney Valuation
$8,500,000
Valuation
$19,700,000
Funding Amount
$11,200,000
Company Info
Founding Year
2020
Traction
Talus Bioscience has secured six non-dilutive grant awards exceeding $7.3M, along with $19.7M in venture funding to date.
Founders
Alex Federation, PhD, Lindsay Pino, PhD
Market
Cancer Therapeutics
Location
Seattle, WA, US
Coinvestors
WRF Capital, NFX, YC Continuity Fund, Funders Club VC, BoxOne Ventures
Company Description

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Drug Discovery DealsView Funding Announcement